Fagron solidifies its leadership position with the acquisition of Guinama in Spain.
Fagron, a global player in pharmaceutical compounding, announces the acquisition of Guinama in Spain.
This acquisition underscores Fagron’s commitment to expanding across their key markets whilst adhering to their acquisition strategy.
Guinama, based in Valencia, Spain, specializes in repackaging and distribution of active pharmaceutical ingredients and excipients to pharmacies, hospitals and industries. It is known for its excellent customer service and strong competitive position, especially for high-volume and fast-moving products.
Guinama strengthens Fagron’s market positioning in the Iberian pharmaceutical compounding market, further solidifying its leading role within the sector and country.
The enterprise value of the acquisition is 22 million euros and the acquisition will close on signing. Guinama generates low double-digit of annual revenue and has an EBITDA margin slightly above Fagron’s existing group margin.
“The acquisition of Guinama aligns perfectly with our disciplined, strategic approach to growth”, says Rafael Padilla, CEO of Fagron. “This acquisition solidifies our repackaging and distribution activities in EMEA, whilst strengthening our market leadership position in Iberia. Key synergies of this integration will come from optimized sourcing, streamlined back-office operations, centralized warehousing, and a shift of production to Poland.”
